Literature DB >> 1777379

Penetration of minocycline into lung tissues.

E Naline1, M Sanceaume, L Toty, H Bakdach, M Pays, C Advenier.   

Abstract

The penetration of minocycline into different lung tissues and bronchial mucus was studied in 17 patients undergoing pulmonary surgery for cancer. The patients received oral minocycline 100 mg at night for 3 days preceding surgery. Minocycline concentrations were measured in plasma samples collected before the operation and in tissues and mucus taken from in and around the part of the lung that was surgically removed. Mean tissue or mucus concentration to plasma concentration ratios were 3.78 +/- 1.10 for lung parenchyma, 4.04 +/- 1.31 for bronchial walls, 3.37 +/- 1.00 for pulmonary arterial walls, 1.99 +/- 1.80 for intraluminal mucus collected from bronchi located in healthy tissue proximal to the tumour, 5.16 +/- 3.26 for intraluminal mucus collected in a bronchus distal to the tumour, and 3.06 +/- 1.99 for catheter-collected mucus from the trachea and principal bronchi. These results indicate that minocycline is found in high concentration in all types of lung tissue and mucus in man.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777379      PMCID: PMC1368539          DOI: 10.1111/j.1365-2125.1991.tb03920.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  The secretion of minocycline in sputum during therapy of bronchopulmonary infection in chronic chest diseases.

Authors:  T D Brogan; L Neale; H C Ryley; B H Davies; J Charles
Journal:  J Antimicrob Chemother       Date:  1977-05       Impact factor: 5.790

Review 2.  Clinical pharmacokinetics of doxycycline and minocycline.

Authors:  S Saivin; G Houin
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

3.  Clinical significance of tissue penetration of antibiotics in the respiratory tract.

Authors:  H P Lambert
Journal:  Scand J Infect Dis Suppl       Date:  1978

4.  Pharmacokinetic studies on minocycline in man.

Authors:  H Macdonald; R G Kelly; E S Allen; J F Noble; L A Kanegis
Journal:  Clin Pharmacol Ther       Date:  1973 Sep-Oct       Impact factor: 6.875

5.  [Concentrations of minocycline in bronchial secretions].

Authors:  A M Clauzel; D Bonnet; J Allegrini; M Simeon de Buochberg
Journal:  Nouv Presse Med       Date:  1978-12-23

6.  Doxycycline and minocycline in the treatment of respiratory infections: a double-blind comparative clinical, microbiological and pharmacokinetic study.

Authors:  F P Maesen; B I Davies; J J van den Bergh
Journal:  J Antimicrob Chemother       Date:  1989-01       Impact factor: 5.790

7.  [Diffusion of minocycline in pulmonary tissue].

Authors:  E Naline; J P Roudière; P Cordonnier; O Varoquaux; N Brion; L Toty; H Bakdach; M Pays; C Advenier
Journal:  Therapie       Date:  1991 Jan-Feb       Impact factor: 2.070

  7 in total
  2 in total

Review 1.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Drug Treatment of Non-Tuberculous Mycobacteria in Cystic Fibrosis.

Authors:  Andrew Burke; Daniel Smith; Chris Coulter; Scott C Bell; Rachel Thomson; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2021-05-13       Impact factor: 5.577

2.  Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.

Authors:  Nobuhisa Ishiguro; Naoko Koseki; Miki Kaiho; Tadashi Ariga; Hideaki Kikuta; Takehiro Togashi; Koji Oba; Keisuke Morita; Naoko Nagano; Masanori Nakanishi; Kazuya Hara; Kyosuke Hazama; Toru Watanabe; Tatsuru Yamanaka; Satoshi Sasaki; Hideto Furuyama; Mutsuo Shibata; Satoru Shida; Akihito Ishizaka; Yuichi Tabata; Hayato Aoyagi; Hiroyuki Naito; Mikio Yoshioka; Atsuko Horino; Tsuyoshi Kenri
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.